Heart Failure

2025

Non-amyloid specific treatment for transthyretin cardiac amyloidosis: a clinical consensus statement of the ESC Heart Failure Association
2025

Future development of arrhythmogenic risk scores in patients with heart failure and inherited dilated cardiomyopathy. A scientific statement of the Heart Failure Association of the ESC
2025

SGLT2 inhibitors for the prevention and treatment of heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the Heart Failure Association of India (HFAI)
2025

Management of aortic stenosis and chronic heart failure. A scientific statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC
2025

Heart failure with preserved ejection fraction in cancer patients and survivors. A Scientific Statement of the Heart Failure Association of the ESC and the ESC Council of Cardio-Oncology
2025

Prevention of cancer therapy-related cardiac dysfunction and heart failure in cancer patients and survivors
2025

Vaccination as a new form of cardiovascular prevention
2025

The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESC
2025

Heat extremes and cardiovascular diseases
2025

The Use of Left Ventricular Ejection Fraction in the Diagnosis and Management of Heart Failure. A Clinical Consensus Statement of Heart failure Association of the European Society of Cardiology (HFA), Heart failure of America (HFSA), Japanese Heart Failure Society (JHFS)
2025

Cardiac implantable electronic and other monitoring devices in continuous-flow left ventricular assist device patients. A clinical consensus statement of the Heart Failure Association and the European Heart Rhythm Association of the ESC
2025

How to handle polypharmacy in heart failure. A Clinical Consensus Statement from the Heart Failure Association of the ESC
2025

Update on Preclinical Models of Cancer Therapy-Related Cardiac Dysfunction: Challenges and Perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-oncology and the ESC Working Group on Cellular Biology of the Heart
2025

Implementation of guideline directed medical therapy in low blood pressure heart Failure with reduced ejection fraction. A Clinical Consensus Statement of the Heart Failure Association of the ESC
2025

Examining the role and preparation of heart failure nurses across Europe. A survey of the Heart Failure Association (HFA) of the ESC and the Association of Cardiovascular Nursing & Allied Professions (ACNAP) of the ESC
2024

State of the art and perspectives of gene therapy in heart failure. A scientific statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases
2024

Examining the clinical role and educational preparation of heart failure nurses across Europe
2024

Awareness, access, and adoption of natriuretic peptides for diagnosis of heart failure
2024

Digital solutions to optimize guideline-directed medical therapy prescription rates in patients with heart failure: a clinical consensus statement from the ESC Working Group on e-Cardiology, the Heart Failure Association of the European Society of Cardiology, the Association of Cardiovascular Nursing & Allied Professions of the European Society of Cardiology, the ESC Digital Health Committee, the ESC Council of Cardio-Oncology, and the ESC Patient Forum
2024

The right heart in patients with cancer. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology
2024

Living with peripartum cardiomyopathy: A statement from the Heart Failure Association and the Association of Cardiovascular Nursing and Allied Professions of the European Society of Cardiology
2024

Cardiovascular toxicities of immune therapies for cancer – a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology
2024

European Society of Cardiology quality indicators update for the care and outcomes of adults with heart failure. The Heart Failure Association of the ESC
2024

Management of cardiac sarcoidosis: A clinical consensus statement of the Heart Failure Association, the European Association of Cardiovascular Imaging, the ESC Working Group on Myocardial & Pericardial Diseases, and the European Heart Rhythm Association of the ESC
2024

Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases
2024

Prevention and rehabilitation after heart transplantation
2024

Right heart failure with left ventricular assist devices: Preoperative, perioperative and postoperative management strategies. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC
2024

Differences in presentation, diagnosis and management of heart failure in women. A scientific statement of the Heart Failure Association of the ESC
2024

Multi-disciplinary care of peripartum heart failure - a Scientific Statement of the Heart Failure Association of the ESC.
2024

A roadmap for therapeutic discovery in pulmonary hypertension due to heart failure (PH-HF). A scientific statement from the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function
2024

Sodium and water intake in heart failure: a Clinical Consensus Statement of the Heart Failure Association of the ESC
2024

Physician perceptions, attitudes, and strategies towards implementing guideline-directed medical therapy in heart failure with reduced ejection fraction. A survey of the Heart Failure Association of the ESC and the ESC Council for Cardiology Practice
2024

Management of cardiac emergencies in women
2024

Integration of Implantable Device Therapy in Patients With Heart Failure. A consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the ESC.
2023
Epidemiology, Pathophysiology, Diagnosis and Management of Chronic Right-Sided Heart Failure and Tricuspid Regurgitation: a clinical consensus statement by the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC.
2023

Interaction of Heart Failure and Stroke: a Clinical Consensus Statement of the Council on Stroke, the Heart Failure Association (HFA) and the Working Group on Thrombosis of the ESC.
2023

Practical Algorithms for Early Diagnosis of Heart Failure and Heart Stress using NT-proBNP: A Scientific Consensus Document of the Heart Failure Association of the ESC.
2023
Competency-based cardiac imaging for patient-centred care. A statement of the European Society of Cardiology (ESC).
2023

Placing patient-reported outcomes at the centre of cardiovascular clinical practice: implications for quality of care and management
2023

Diagnosis and Management of Patients with Left Ventricular Hypertrophy: Role of Multimodality Cardiac Imaging. A Scientific Statement of the Heart Failure Association of the ESC
2023

Culture, ethnicity and socio-economic status as determinants of the management of patients with advanced heart failure and need palliative care: A Clinical Consensus Statement from the Heart Failure Association (HFA) of the ESC, the ESC Patient Forum, and the European Association of Palliative Care.
2023

Heart Failure Diagnosis in the General Community: Who, How and When: a scientific statement of the Heart Failure Association (HFA) of the ESC
2023

Acute Heart Failure and Valvular Heart Disease: a joint scientific statement of Heart Failure Association (HFA), the Association for Acute Cardiovascular Care (ACVC) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC.
2023

Patient Phenotype Profiling in Heart Failure with Preserved Ejection Fraction to Guide Therapeutic Decision Making. A Joint Scientific Statement of the Heart Failure Association (HFA) and the European Heart Rhythm Association (EHRA) of ESC & of the European Hypertension Society (ESH).
2023

Pre-discharge and early post-discharge management of patients hospitalized for acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC
2023

Worsening heart failure in clinical practice. A scientific statement of the Heart Failure Association (HFA) of the ESC
2023

Natriuretic peptides: Role in the diagnosis and management of heart failure. A Scientific Statement of the Heart Failure Association (HFA) of the ESC, the Japanese Heart Failure Society, and the Heart Failure Society of America.
2023

Inotropic therapy in chronic heart failure. A clinical consensus statement from the Heart Failure Association of the ESC
2022
Biomarkers in Clinical Trials in Heart Failure- Position paper of the HFA of the ESC
2022

Myocarditis Following COVID-19 Vaccine: Incidence, Presentation, Diagnosis, Pathophysiology, Therapy, and Outcomes put into Perspective. Clinical Consensus Document supported by the Heart Failure Association of the ESC and the ESC Working Group on Myocardial and Pericardial Disease
2022

Circulating and non-circulating biomarkers in congestion- Position paper of the HFA of the ESC
2022

Exercise Testing in HFpEF: an Appraisal Through Diagnosis, Pathophysiology and Therapy. A Clinical Consensus Statement of the Heart Failure Association (HFA) and European Association of Preventive Cardiology (EAPC) of the European Society of Cardiology (ESC)
2022

Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology
2022

Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology
2020

Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio‐Oncology Study Group of the Heart Failure Association and the Cardio‐Oncology Council of the European Society of Cardiology
2020

Self‐care of heart failure patients: practical management recommendations from the Heart Failure Association of the European Society of Cardiology
2020

Integration of a palliative approach into heart failure care
2020

Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies
2020

Sodium–glucose co‐transporter 2 inhibitors in heart failure: beyond glycaemic control
2020

Epidemiology, Pathophysiology and Contemporary Management of Cardiogenic Shock
2020

Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies
2020
Evaluation of kidney function throughout the heart failure trajectory
2019
Sex and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry
2019

The role and safety of new glucose‐lowering drugs in patients with heart failure
2019

Imaging in patients with suspected acute heart failure
2019

Brachial pulse pressure in acute heart failure
2019

Frailty in patients with heart failure
2019

How to diagnose heart failure with preserved ejection fraction
2019

Regional differences in exercise training implementation in heart failure
2019

Pathophysiology, diagnosis and management of peripartum cardiomyopathy
2019

Practical guidance on the use of natriuretic peptide concentrations
2019

Reporting checklist for quantification of pulmonary congestion by lung ultrasound in heart failure
2019

Sacubitril/valsartan eligibility and outcomes in the ESC‐EORP‐HFA Heart Failure Long‐Term Registry
2019

Clinical practice update on heart failure 2019
2019

Acute heart failure congestion and perfusion status – impact of the clinical classification on in‐hospital and long‐term outcomes
2019

Heart failure in cardiomyopathies
2019

The role of ventricular–arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions
2019

Towards better definition, quantification and treatment of fibrosis in heart failure
2019

The use of diuretics in heart failure with congestion
2018

Innovative imaging methods in heart failure: a shifting paradigm in cardiac assessment
2018

Exercise training in patients with ventricular assist devices: a review of the evidence and practical advice
2018

Afib in HF EORP
2018

Heart failure and diabetes: metabolic alterations and therapeutic interventions
2018

Treatments targeting inotropy
2018

Advanced HF
2018

Long‐term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy
2018

Type 2 diabetes mellitus and heart failure
2018

An integrative translational approach to study heart failure with preserved ejection fraction
2018

Long-term safety of intravenous cardiovascular agents in acute heart failure
2018

Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge
2018

Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease
2017

Heart and brain interaction in patients with heart failure: overview and proposal for a taxonomy
2017

Indications and practical approach to non-invasive ventilation in acute heart failure
2017

Clinical phenotypes and outcome of patients hospitalized for acute heart failure
2017

Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management
2017

The autonomic nervous system as a therapeutic target in heart failure
2017

Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM)
2017

Role of cardiopulmonary exercise testing in clinical stratification in heart failure
2017

Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management
2016

Cancer treatments and cardiovascular toxicity
2016

Current management of patients with severe acute peripartum cardiomyopathy
2016

Contemporary management of acute right ventricular failure
2016

Treatment of heart failure in adult congenital heart disease
2015

Current state of knowledge on Takotsubo syndrome
2015

Arrhythmias in heart failure
2015

Recommendations on pre-hospital & hospital management of acute heart failure
2015

Cardiac Oncology Toxicity Registry in breast cancer patients: rationale, study design, and methodology (EACVI/HFACOT Registry)
2014

Cardiovascular side effects of cancer therapies
2014

Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy
2013

New devices in heart failure
2012

EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management

Consensus and Position Papers on Heart Failure

Heart Failure Association of the ESC (HFA)